Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trial

作者：Hong Zhao, Chi Zhang, Qi Zhu, Xianxiang Chen, Guilin Chen, Wenjin Sun, Zuohan Xiao, Wei-Jun Du, Jing Yao, Guojun Li, Yanhua Ji, Niuniu Li, Yujin Jiang, Ying Wang, Qingjin Zeng, Wei Li, Beilei Gong, Xianyou Chang, Feng Zhu, Xiufeng Jiang, Jiawen Li, Zhao Wu, Yingxia Liu, Peng Peng, Guiqiang Wang · 发表于：International Immunopharmacology · 年份：2021 · DOI：10.1016/j.intimp.2021.107702 · 被引用次数：43 · 研究领域：COVID-19 Clinical Research Studies、SARS-CoV-2 detection and testing、Long-Term Effects of COVID-19